News

February 3, 2016February 3, 2016

Inflammation During Pregnancy Linked to Autism Through Immune Response

News

Pregnant women who develop severe infections are known to more frequently give birth to children with autism, and a collaborative team of researchers working with a mouse model have identified a possible ... Read more

February 1, 2016February 1, 2016

Treating Severe Rheumatoid Arthritis Gets Boost With Health Agency’s Recommendation

News

Britain’s National Institute for Health and Care Excellence (NICE) has issued a final guidance recommending the use of seven specific biological disease modifying drugs (DMARDs) as options for treating severe rheumatoid arthritis ... Read more

January 29, 2016May 23, 2016

AbbVie Launches Phase 3 Trial for Rheumatoid Arthritis

News

AbbVie announced the start of a robust Phase 3 clinical trial to analyze the use of ABT-494 – an investigational oral selective JAK1 inhibitor – in the treatment of rheumatoid arthritis (RA). The ... Read more

January 27, 2016January 27, 2016

Rheumatoid Arthritis Risk Increases Greatly With Exposure to Occupational Textile Dust

News

Occupational exposure to textile dust more than doubles the risk of developing rheumatoid arthritis, according to a study published in the Annals of the Rheumatic Diseases titled “Occupational exposure to textile dust increases ... Read more

January 25, 2016May 23, 2016

Rheumatoid Arthritis Drug Candidate Advances to FDA’s New Drug Application Program

News

Indianapolis-based Eli Lilly & Company and Incyte Corp announced that Lilly has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval of baricitinib, a ... Read more

January 20, 2016January 20, 2016

Rheumatoid Arthritis Gene-Regulating Mechanisms Uncovered

News

Yale School of Medicine researchers have uncovered the molecular key players that regulate a gene known to be linked to susceptibility to infectious and autoimmune diseases such as rheumatoid arthritis. The ... Read more

January 15, 2016January 15, 2016

AbbVie Launches Phase 3 Trials to Evaluate Drug for Rheumatoid Arthritis

News

Illinois-based AbbVie, a global pharmaceutical company, has launched a robust Phase 3 clinical trial program to evaluate the investigational drug ABT-494 in the treatment of rheumatoid arthritis (RA). The program will enroll adults with inadequate ... Read more

January 13, 2016January 13, 2016

Potential Rheumatoid Arthritis Therapy Under FDA Review

News

Regeneron Pharmaceuticals, Inc., and Sanofi announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for sarilumab, an investigational, human monoclonal antibody intended to treat patients with ... Read more

January 11, 2016January 11, 2016

Potential Rheumatoid Arthritis Treatment Phase 3 Trial Protocol Submitted

News

Can-Fite BioPharma Ltd. announced it has submitted its Phase 3 clinical trial protocol to the Institutional Review Board (IRB) of Barzilai Medical Center in Israel, and will also file similar ... Read more

January 8, 2016January 8, 2016

Maple Syrup Molecule has Anti-Inflammatory Properties, Possible Rheumatoid Arthritis Treatment

News

Researchers at Canada’s Université Laval have demonstrated the powerful anti-inflammatory effects of quebecol, a maple syrup compound, along with its derivatives, offering promise for the development of anti-inflammatory therapies targeting autoimmune diseases ... Read more